Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2002
12/31/2002US6500427 One-component tissue adhesive and a process for the production thereof
12/31/2002US6500422 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3)
12/31/2002US6500420 Agents can be used to regulate blood flow to a wound site promoting wound healing
12/31/2002US6500418 Stimulating neutrophil function to treat inflammatory bowel disease
12/31/2002CA2281673C Methods for administering nutritional indium
12/31/2002CA2201944C Analogs of keratinocyte growth factor having enhanced temperature stability
12/31/2002CA2096532C New human recombinant gamma-interferon
12/31/2002CA2079443C Binding of growth hormone to liposomes
12/31/2002CA2069460C Methods and compositions for preparation and use of a herpes protease
12/31/2002CA1341414C Expression vectors of hirudine, transformed cells and process for the preparation of hirudine
12/29/2002CA2392383A1 A complex comprising ocif and polysaccharide
12/27/2002WO2002103513A1 Essential and important genes of pseudomonas aeruginosa and the use thereof to design or identify antibacterial agents
12/27/2002WO2002103027A1 Glycoprotein and process for producing the same
12/27/2002WO2002103026A2 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
12/27/2002WO2002103024A2 Stabilized proteins with engineered disulfide bonds
12/27/2002WO2002103020A1 Novel disease-associated gene and use thereof
12/27/2002WO2002103018A1 Novel polypeptide and use thereof
12/27/2002WO2002103016A2 Human tachykinin-related splice variants and compositions thereof
12/27/2002WO2002103015A2 Abca10 transporter
12/27/2002WO2002103014A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002WO2002103006A1 Guanosine triphosphate-binding protein-coupled receptors
12/27/2002WO2002103005A1 Guanosine triphosphate-binding protein-coupled receptors
12/27/2002WO2002103004A1 Surface modification for improving biocompatibility
12/27/2002WO2002102996A1 Male contraceptives
12/27/2002WO2002102994A2 Human secreted proteins
12/27/2002WO2002102993A2 Human secreted proteins
12/27/2002WO2002102992A2 Novel nucleic acids, polypeptides, methods of making, and uses thereof
12/27/2002WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same
12/27/2002WO2002102987A2 Methods and compositions based on protein interactions with mastermind
12/27/2002WO2002102986A2 Novel human transporter proteins and polynucleotides encoding the same
12/27/2002WO2002102984A2 Hdac9 polypeptides and polynucleotides and uses thereof
12/27/2002WO2002102978A2 Human growth hormone antagonists
12/27/2002WO2002102976A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002WO2002102975A2 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans
12/27/2002WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002WO2002102845A1 Process for producing silk fibroin-origin functional polypeptide and utilization thereof
12/27/2002WO2002102836A2 Moraxella (branhamella) catarrhalis antigens
12/27/2002WO2002102835A2 Novel antimicrobial compounds
12/27/2002WO2002102833A1 Novel endomorphine derivatives
12/27/2002WO2002102832A1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
12/27/2002WO2002102831A1 Process for extracting collagen from marine invertebrates
12/27/2002WO2002102828A2 Chimeric flavivirus vectors
12/27/2002WO2002102445A1 Dry powder inhalation system for transpulmonary administration
12/27/2002WO2002102414A1 Medicinal compositions
12/27/2002WO2002102412A2 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons
12/27/2002WO2002102406A1 Use of glycoprotein for the treatment and re-epithelialisation of wounds
12/27/2002WO2002102405A1 The use of bacterial phage associated lytic enzymes to prevent food poisoning
12/27/2002WO2002102404A1 Uses of cytokines
12/27/2002WO2002102403A1 Mucosal repair by tff dimer peptides
12/27/2002WO2002102402A1 Anticancer agents
12/27/2002WO2002102401A1 Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists
12/27/2002WO2002102399A2 Mucosal repair by tff2 peptides
12/27/2002WO2002102394A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/27/2002WO2002102390A1 Enhanced drug delivery in transdermal systems
12/27/2002WO2002102361A1 Remedies for diseases caused by nonsense mutation
12/27/2002WO2002102321A2 Novel proteins and nucleic acids encoding same
12/27/2002WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma
12/27/2002WO2002102319A2 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue
12/27/2002WO2002102318A2 Eglin c based drugs for treatment of disease
12/27/2002WO2002102316A2 Histone deacetylase and methods of use thereof
12/27/2002WO2002102312A2 Combination therapy of gamma-interferon and b cell specific antibodies
12/27/2002WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002WO2002102309A2 Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders
12/27/2002WO2002102306A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002WO2002102232A2 A novel signaling pathway for the production of inflammatory pain and neuropathy
12/27/2002WO2002102229A2 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002WO2002092805A8 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tuberculosis
12/27/2002WO2002085409A3 Methods and compositions for inducing an immune response to an antigen
12/27/2002WO2002072619A9 INTEGRIN αIIbβ3 ACTIVATING PEPTIDES AND THEIR USE
12/27/2002WO2002072144A9 Remedies for nerve damages
12/27/2002WO2002066620A3 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system
12/27/2002WO2002066072A9 Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor
12/27/2002WO2002061036A3 Method of complexing a protein by the use of a dispersed system and proteins thereof
12/27/2002WO2002057415A3 Method for altering cell fate
12/27/2002WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002WO2002056907A3 Molecular antigen array presenting amyloid beta
12/27/2002WO2002055099A3 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
12/27/2002WO2002053142A3 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
12/27/2002WO2002051994A3 Polypeptides
12/27/2002WO2002049676A3 Compositions containing inclusion complexes
12/27/2002WO2002049593A3 Use of dna repair enzymes as mmp-1 inhibitors
12/27/2002WO2002047709A3 Resistant thymidylate synthase mutants for locally treating a chemotherapy-induced mucositis and other side effects associated with chemotherapy
12/27/2002WO2002047612A3 Dietary supplement compositions
12/27/2002WO2002042452A3 Adapter protein and gene encoding it
12/27/2002WO2002038795A3 Braf35 protein and brca2/braf35 complex and methods of use
12/27/2002WO2002036635A3 Monoclonal antibodies for assaying lipid transfer proteins
12/27/2002WO2002031125A3 Human phospholipase a2-like enzyme
12/27/2002WO2002029052A3 Regulation of human secretin receptor-like gpcr
12/27/2002WO2002026968A3 Antisense iap nucleic acids and uses thereof
12/27/2002WO2002024908A9 Novel tissue-specific secretory polypeptide and dna thereof
12/27/2002WO2002024234A3 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
12/27/2002WO2002020610A3 Conformationally constrained labeled peptides for imaging and therapy
12/27/2002WO2002016593A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/27/2002WO2002012467A3 Drug metabolizing enzymes
12/27/2002WO2002010379B1 Modified cea and uses thereof
12/27/2002WO2002008257A3 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
12/27/2002WO2002005854A3 Bridged glycoconjugates
1 ... 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 ... 3163